American Tower Sees Slightly Weaker US Growth As International Performance Strengthens

American Tower (AMT) reported Q2 revenue up 3.2% to $2.63 billion and adjusted EBITDA up 1.8%, with shares trading lower despite results and 2025 guidance largely aligning with Street expectations. Goldman Sachs suggests the stock will remain range-bound, noting investor optimism for future domestic organic growth and potential cost-cutting is tempered by a slight softening in U.S. growth projections and persistent risks from high interest rates and unfavorable foreign exchange movements, even as the international outlook improved slightly.

Analysis

American Tower Corporation (AMT) reported modest second-quarter growth, with total revenue increasing 3.2% to $2.63 billion and adjusted EBITDA rising 1.8% to $1.75 billion. Despite these figures and 2025 guidance largely aligning with Street expectations, the company's shares traded down 3.51%. The market's muted reaction reflects a mixed outlook where positive factors are balanced by tangible risks. According to Goldman Sachs, investor optimism is centered on expectations for stronger domestic organic growth toward year-end, potential cost-cutting initiatives in the latter half of 2025, and sector-leading AFFO per share growth. However, this is tempered by a slight decline in the U.S. organic growth projection, a critical detail given that competitor Crown Castle (CCI) recently raised its own domestic outlook. The company has benefited from a weaker U.S. dollar, but significant downside risks remain, including sustained high interest rates, international macroeconomic instability, and potential for adverse foreign exchange movements, leading to the analyst's assessment that the stock will likely remain range-bound in the near term.

Key Decisions for Investors

• Given that results and guidance were in-line with expectations, investors may consider holding existing positions while monitoring for specific catalysts mentioned, such as a cost-cutting update in H2 2025 or signs of accelerating domestic growth.
• The stock's negative reaction, coupled with a softening U.S. growth outlook and a stronger report from peer Crown Castle, suggests caution for those considering new positions until management provides more clarity on its competitive standing during the earnings call.
• It is critical to assess the portfolio's exposure to macroeconomic headwinds, as sustained high interest rates and unfavorable currency movements were explicitly cited as key downside risks that could challenge the stock's performance.